Brazil vs Switzerland: Treatment success rate for patients treated for MDR-TB
Brazil
60.0%
in 2022
Switzerland
60.0%
in 2022
Brazil rank
120th
Switzerland rank
120th
Treatment success rate for patients treated for MDR-TB over time
- Brazil
- Switzerland
How they compare
Brazil currently reports 60.0% against 60.0% in Switzerland, a difference of 0.0%.
The two have swapped places 4 times across 9 shared years of data; in 2014 it was Switzerland ahead.
Brazil ranks 120th and Switzerland ranks 120th of 163 countries.
Across the 2 decades both report, Brazil averaged higher in 1 and Switzerland in 1.
Head to head by decade
| Decade | Brazil | Switzerland | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 57.5% | 68.0% | 10.5% | Switzerland |
| 2020s | 55.3% | 53.3% | 2.0% | Brazil |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher treatment success rate for patients treated for mdr-tb, Brazil or Switzerland?
- Brazil, at 60.0% against 60.0% in Switzerland as of 2022.
- What is the difference in treatment success rate for patients treated for mdr-tb between Brazil and Switzerland?
- 0.0%, with Brazil ahead.
- How many years of comparable data are there for Brazil and Switzerland?
- 9 years are reported by both, from 2014 to 2022.
- How do Brazil and Switzerland rank globally for treatment success rate for patients treated for mdr-tb?
- Brazil ranks 120th and Switzerland ranks 120th of 163 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Treatment success rate for patients treated for MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.